Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prof Sten Eirik W. Jacobsen elected as EMBO member

Awards and Appointments General

Many congratulations to Professor Jacobsen from MRC Molecular Haematology Unit and Radcliffe Department of Medicine, for this distinction, which recognises his research unravelling the haematopoietic roadmap.

This honour recognizes how Professor Jacobsen's work has impacted our understanding of normal and dysregulated stem cell biology and lineage specification, with a direct clinical impact on the management of blood disorders.

Prof Jacobsen pioneered research examining how mature blood cells are produced from haematopoietic stem cells (HSCs), in particular by unravelling new pathways of lineage commitment, in work that has redrawn the “textbook” roadmap of normal hematopoiesis. His work has also influenced the field’s thinking on the processes underlying stem cell fate decisions and stem cell heterogeneity. In particular, his team showed that not all HSCs are destined to form all mature blood cell types despite possessing multipotency.

Read more (MRC Weatherall for Molecular Medicine website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

Tinnitus seems linked with sleep – understanding how could bring us closer to finding a cure

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.